FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

FDA Sets Combination Product Postmarketing Safety Reports

[ Price : $8.95]

FDA proposes a rule to specify clarified postmarketing safety reporting requirements for combination products.

Mylan Wants Stay for High-load Duragesic

[ Price : $8.95]

Mylan asks FDA to not approve any fentanyl transdermal products containing a substantially higher drug load than current patches.

EMD Serono Submits NDA for MS Drug

[ Price : $8.95]

EMD Serono has submitted an NDA to FDA for cladribine tablets for therapy to reduce relapses in people with relapsing forms of mul...

Info on Humanitarian Device Exemption Sent to OMB

[ Price : $8.95]

Federal Register Notice: FDA submits a proposed collection of information on humanitarian device exemption regulations to the Offi...

Latest FDA Warning Letters

[ Price : $8.95]

In its latest batch of Warning Letters, FDA cites Arjo Med, Banyan Botanicals, Bioniche Pharma, Ion Labs, John Kirkwood, and Netpr...

Panel to Discuss Antibacterial Drug Labeling

[ Price : $8.95]

Federal Register Notice: FDAs Anti-Infective Drugs Advisory Committee will meet 10/26 to discuss updating susceptibility test info...

BIO Has Many Questions on ICH Genomic Biomarker Guidance

[ Price : $8.95]

BIO raises a number of questions and clarification requests on FDAs draft ICH genomic biomarker guidance.

Blood Panel to Meet

[ Price : $8.95]

Federal Register Notice: FDAs Blood Products Advisory Committee will meet 11/16-17 to discuss various topics such as the 2009 A/H1...

FDA Extends Glaxo Review of Cervarix

[ Price : $8.95]

FDA extends its review of GlaxoSmithKlines BLA for Cervarix cervical cancer vaccine.

FDA and Caraco Reach Consent Decree on Firms GMPs

[ Price : $8.95]

Caraco Pharmaceutical Laboratories enters into a consent decree with FDA over the firms ongoing GMP troubles associated with its g...